Post-approval studies (Phase 4)UnknownNCT01698866What this trial is testingLow Grade LymphomaWho this might be right forIndolent Lymphoproliferative Disorders Central Hospital, Nancy, France 40
Testing effectiveness (Phase 2)WithdrawnNCT01238146What this trial is testingObatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT03498612What this trial is testingPembrolizumab in Untreated B-Cell Non-Hodgkin Lymphoproliferative DiseasesWho this might be right forFollicular LymphomaIndolent B-Cell Non-Hodgkin LymphomaMarginal Zone Lymphoma University of Washington 9
Testing effectiveness (Phase 2)Study completedNCT00085696What this trial is testingVELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell LymphomaWho this might be right forB-Cell LymphomaFollicular LymphomaMarginal Lymphoma Millennium Pharmaceuticals, Inc. 66
Early research (Phase 1)Active Not RecruitingNCT04323956What this trial is testingParsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell LymphomaWho this might be right forAnn Arbor Stage II Diffuse Large B-Cell LymphomaAnn Arbor Stage II Follicular LymphomaAnn Arbor Stage II Marginal Zone Lymphoma+11 more Mayo Clinic 50
Large-scale testing (Phase 3)UnknownNCT02991638What this trial is testingEfficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus CarriersWho this might be right forChronic Lymphocytic LeukemiaIndolent B-cell LymphomasChronic Hepatitis B+4 more The University of Hong Kong 62
Early research (Phase 1)Study completedNCT00082784What this trial is testingBortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell NeoplasmsWho this might be right forExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+10 more National Cancer Institute (NCI) 93
Early research (Phase 1)WithdrawnNCT04836832What this trial is testingAcalabrutinib and Duvelisib for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin LymphomaWho this might be right forRecurrent Follicular LymphomaRecurrent Marginal Zone LymphomaRecurrent Nodal Marginal Zone Lymphoma+6 more Narendranath Epperla
Testing effectiveness (Phase 2)Study completedNCT00005579What this trial is testingDolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma University of Vermont
Early research (Phase 1)Study completedNCT00052416What this trial is testingThalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma Beth Israel Deaconess Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT00110149What this trial is testingRituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Beth Israel Deaconess Medical Center 12
Early research (Phase 1)Study completedNCT00060684What this trial is testingDose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's LymphomaWho this might be right forLymphoma, Low-GradeLymphoma, Small LymphocyticLymphoma, Mixed-Cell, Follicular+1 more CTI BioPharma 30
Testing effectiveness (Phase 2)Study completedNCT01926639What this trial is testingPhase II Cancer Vaccine Trial for Patients With Follicular LymphomaWho this might be right forFollicular Lymphoma Oslo University Hospital 14
Large-scale testing (Phase 3)Ended earlyNCT00060671What this trial is testingComparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's LymphomaWho this might be right forLymphoma, FollicularLymphoma, Mixed-Cell, FollicularLymphoma, Small Cleaved-Cell, Follicular+1 more CTI BioPharma 800
Not applicableStudy completedNCT00574730What this trial is testingCHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkins Lymphoma University of Nebraska 27
Testing effectiveness (Phase 2)Study completedNCT00875056What this trial is testingStudy of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103)Who this might be right forLymphoma Merck Sharp & Dohme LLC 56
Large-scale testing (Phase 3)WithdrawnNCT02576275What this trial is testingDuvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA)Who this might be right forIndolent Non-Hodgkin's LymphomaFollicular LymphomaSmall Lymphocytic Lymphoma+1 more SecuraBio
Early research (Phase 1)Looking for participantsNCT04223765What this trial is testingStudy of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.Who this might be right forMantle Cell LymphomaFollicular LymphomaSplenic Marginal Zone Lymphoma+3 more UNC Lineberger Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)WithdrawnNCT00004039What this trial is testingCombination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV LymphomaWho this might be right forLymphoma Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)Study completedNCT03105336What this trial is testingAxicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin LymphomaWho this might be right forFollicular LymphomaMarginal Zone LymphomaIndolent Non-Hodgkin Lymphoma Kite, A Gilead Company 159